Dennis Ding

Stock Analyst at Jefferies

(1.20)
# 3,736
Out of 5,045 analysts
15
Total ratings
40%
Success rate
-2.18%
Average return

Stocks Rated by Dennis Ding

Roivant Sciences
Sep 18, 2025
Maintains: Buy
Price Target: $18$20
Current: $19.58
Upside: +2.15%
Mineralys Therapeutics
Sep 3, 2025
Maintains: Hold
Price Target: $15$26
Current: $41.12
Upside: -36.77%
Indivior
Jul 22, 2025
Assumes: Buy
Price Target: $20
Current: $29.13
Upside: -31.34%
Crinetics Pharmaceuticals
Jan 22, 2025
Upgrades: Buy
Price Target: $55
Current: $43.28
Upside: +27.08%
Inhibikase Therapeutics
Nov 8, 2024
Initiates: Buy
Price Target: $8
Current: $1.45
Upside: +451.72%
Assembly Biosciences
Sep 20, 2024
Upgrades: Buy
Price Target: $2$35
Current: $30.12
Upside: +16.20%
Amicus Therapeutics
Sep 6, 2024
Initiates: Buy
Price Target: $18
Current: $8.91
Upside: +102.13%
Arbutus Biopharma
Sep 5, 2024
Maintains: Buy
Price Target: $5$7
Current: $4.84
Upside: +44.78%
Recursion Pharmaceuticals
Sep 3, 2024
Maintains: Hold
Price Target: $8$6
Current: $5.65
Upside: +6.19%
Lyra Therapeutics
May 7, 2024
Downgrades: Hold
Price Target: $500$25
Current: $5.52
Upside: +352.90%
Downgrades: Hold
Price Target: $35$22
Current: $72.26
Upside: -69.55%
Initiates: Buy
Price Target: $24
Current: $38.72
Upside: -38.02%